Metabolic and hematologic changes occurring after rapid intravenous infusion of gammaglobulin in patients with antibody deficiency syndromes
Keywords:
Intravenous immunoglobulin, Immunodeficiency, Side effects, Infusion rates, LeukopeniaAbstract
OBJECTIVE: We wished to investigate whether increased IgG infusion rates are associated with metabolic and hematologic changes in pediatric patients with antibody deficiency syndromes. METHODS: We studied 7 patients (2-16 years old) with primary antibody deficiencies who had been on regular IgG replacement treatment, 350-600 mg/kg/dose every 3 weeks with a 3% IVIG preparation, for periods ranging from 6 months to 4 years. Initially, the IgG concentration of IVIG preparations was increased to 6, 9 and 12% in consecutive infusions at a constant IgG infusion rate of 4 mg/kg/min. Subsequently, the infusion rates were increased to 8, 12, and 16 mg/kg/min using the IVIG 12% preparation. RESULTS: Clinically, all patients tolerated increases in IVIG concentrations while the infusion rate was 4 mg/kg/min. However, 3 patients presented side effects when the infusion rate was increased to 8 and 16 mg/kg/min. CONCLUSION: We conclude that metabolic and hematologic sides effects occur with rapid infusion of IVIG even in patients who tolerate the increased infusion rate clinically. The advantages of using high infusion rates have to be re-evaluated.
Downloads
References
Appropriate uses of human immunoglobulin in clinical practice. Memorandum from an IUIS/WHO meeting. Bull WHO 1982;60:43-7.
Haeney M. Intravenous immune globulin in primary immunodeficiency. Clin Exp Immunol 1994;97(Suppl1):11-5.
Imbach P, Barandin S, d'Apuzzo V. High-dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;1:1228.
Nydegger UE. Intravenous immunoglobulin in combination with other prophylactic and therapeutic measures. Transfusion 1992;32:72-82.
Duhem C, Dicato MA, Ries F. Side-effects of intravenous immune globulins. Clin Exp Immunol 1994;97(Suppl1):79-83.
NIH Consensus Conference. Intravenous immunoglobulin: prevention and treatment of disease. JAMA 1990;264(24):3189-93.
Frey AM. Part II: Administration of immune globulin. Journal of Intravenous Nursing 1991;14(6):396-405.
Schiff RI, Sedlak D, Buckley RH. Rapid infusion of sandoglobulin in patients with primary humoral immunodeficiency. J Allergy Clin Immunol 1991;88:61-7.
Misbah SA, Chapel HM. Adverse effects of intravenous immunoglobulin. Drug Experience 1993;9(4):254-62.
Ramirez MV, Charlet M, Parry GJ. Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 1992;42:1636-7.
Camp-Sorrell D, Wujcik D. Intravenous immunoglobulin administration: an evaluation of vital sign monitoring. Oncol Nurs Forum 1994;21(3):531-4.
Reinhart WH, Berchtold PE. Effect of high-dose intravenous immunoglobulin therapy on blood rheology. Lancet 1992;339:662-4.
Pasatiempo AM, Kroser JA, Rudnick M, Hoffman BI. Acute renal failure after intravenous immunoglobulin therapy. J Rheumatol 1994;21:347-9.
Woodruff RK, Grigg AP, Firkin FC, Smith IL. Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in eldery patients. Lancet 1986;2:217-8.
Buckley RH, Schiff RI. The use of intravenous immunoglobulin in immunodeficiency diseases. N Engl J Med 1991;325:110-7.
Ben-Chetrit E, Putterman C. Transient neutropenia induced by intravenous immune globulin. N Engl J Med 1992;326(4):270-1.
Lassiter HA, Bibb KW, Bertolone SJ, Patel CC, Stroncek DF. Neonatal immune neutropenia following the administration of intravenous immune globulin. Am J Pediatr Hematol Oncol 1993;15:120-3.
O'Donnell JL, Roberts-Thomson PJ, Ahern MJ, Bradley J. Alteration in circulating neutrophil CR3 density associated with immunoglobulin infusion. Aust N Z J Med 1988;18:95-100.
Burdach EG, Evers KG, Geursen RG. Treatment of acute idiopathic thrombocytopenic purpura of childhood with intravenous immunoglobulin G: comparative efficacy of 7S and 5S preparations. J Pediatr 1986;109:770-5.
Bussel JB, Kimberly RP, Inman RD, Schulman I, Cunningham-Rundles C, Cheung N, et al. Intravenous gammagobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood 1983;62(2):480-6.
